Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist

被引:18
|
作者
Chiara, DC [1 ]
Trinidad, JC [1 ]
Wang, D [1 ]
Ziebell, MR [1 ]
Sullivan, D [1 ]
Cohen, JB [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
关键词
D O I
10.1021/bi0269815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[H-3]4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine (TDBzcholine) was synthesized and used as a photoaffinity probe to map the orientation of an aromatic choline ester within the agonist binding sites of the Torpedo nicotinic acetylcholine receptor (nAChR). TDBzcholine acts as a nAChR competitive antagonist that binds at equilibrium with equal affinity to both agonist sites (K-D similar to 10 muM). Upon UV irradiation (350 nm), nAChR-rich membranes equilibrated with [H-3]TDBzcholine incorporate H-3 into the alpha, gamma, and delta subunits in an agonist-inhibitable manner. The specific residues labeled by [H-3]TDBzcholine were determined by N-terminal sequence analysis of subunit fragments produced by enzymatic cleavage and purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and/or reversed-phase high-performance liquid chromatography. For the alpha subunit, [H-3]TDBzcholine photoincorporated into alphaCys192, alphaCys-193, and alphaPro-194. For the gamma and delta subunits, [H-3]TDBzcholine incorporated into homologous leucine residues, gammaLeu-109 and deltaLeu-111. The photolabeling of these amino acids suggests that when the antagonist TDBzcholine occupies the agonist binding sites, the Cys- 192-193 disulfide and Pro-194 from the alpha subunit Segment C are oriented toward the agonist site and are in proximity to gammaLeu- 109/deltaLeu-111 in Segment E, a conclusion consistent with the structure of the binding site in the molluscan acetylcholine binding protein, a soluble protein that is homologous to the nAChR extracellular domain.
引用
收藏
页码:271 / 283
页数:13
相关论文
共 50 条
  • [31] Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914)
    Ghiron, Chiara
    Haydar, Simon N.
    Aschmies, Suzan
    Bothmann, Hendrick
    Castaldo, Cristiana
    Cocconcelli, Giuseppe
    Comery, Thomas A.
    Di, Li
    Dunlop, John
    Lock, Tim
    Kramer, Angela
    Kowal, Dianne
    Jow, Flora
    Grauer, Steve
    Harrison, Boyd
    La Rosa, Salvatore
    Maccari, Laura
    Marquis, Karen L.
    Micco, Iolanda
    Nencini, Arianna
    Quinn, Joanna
    Robichaud, Albert J.
    Roncarati, Renza
    Scali, Carla
    Terstappen, Georg C.
    Turlizzi, Elisa
    Valacchi, Michela
    Varrone, Maurizio
    Zanaletti, Riccardo
    Zanelli, Ugo
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (11) : 4379 - 4389
  • [32] IDENTIFICATION OF A NOVEL AMINO-ACID ALPHA-TYROSINE-93 WITHIN THE CHOLINERGIC LIGANDS-BINDING SITES OF THE ACETYLCHOLINE-RECEPTOR BY PHOTOAFFINITY-LABELING - ADDITIONAL EVIDENCE FOR A 3-LOOP MODEL OF THE CHOLINERGIC LIGANDS-BINDING SITES
    GALZI, JL
    REVAH, F
    BLACK, D
    GOELDNER, M
    HIRTH, C
    CHANGEUX, JP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (18) : 10430 - 10437
  • [33] Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase
    Heerding, Dirk A.
    Rhodes, Nelson
    Leber, Jack D.
    Clark, Tammy J.
    Keenan, Richard M.
    Lafrance, Louis V.
    Li, Mei
    Safonov, Igor G.
    Takata, Dennis T.
    Venslavsky, Joseph W.
    Yamashita, Dennis S.
    Choudhry, Anthony E.
    Copeland, Robert A.
    Lai, Zhihong
    Schaber, Michael D.
    Tummino, Peter J.
    Strum, Susan L.
    Wood, Edgar R.
    Duckett, Derek R.
    Eberwein, Derek
    Knick, Victoria B.
    Lansing, Timothy J.
    McConnell, Randy T.
    Zhang, ShuYun
    Minthorn, Elisabeth A.
    Concha, Nestor O.
    Warren, Gregory L.
    Kumar, Rakesh
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) : 5663 - 5679
  • [34] Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
    Zanaletti, Riccardo
    Bettinetti, Laura
    Castaldo, Cristiana
    Cocconcelli, Giuseppe
    Comery, Thomas
    Dunlop, John
    Gaviraghi, Giovanni
    Ghiron, Chiara
    Haydar, Simon N.
    Jow, Flora
    Maccari, Laura
    Micco, Iolanda
    Nencini, Arianna
    Scali, Carla
    Turlizzi, Elisa
    Valacchit, Michela
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4806 - 4823
  • [35] AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4] oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus
    Li, Zhu
    Bonhaus, Douglas W.
    Huang, Mei
    Prus, Adam J.
    Dai, Jin
    Meltzer, Herbert Y.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 572 (2-3) : 129 - 137
  • [36] Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents:: Detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]
    Satow, Akio
    Maehara, Shunsuke
    Ise, Satoko
    Hikichi, Hirohiko
    Fukushima, Miyuki
    Suzuki, Gentaroh
    Kimura, Toshifumi
    Tanaka, Takeshi
    Ito, Satoru
    Kawamoto, Hiroshi
    Ohta, Hisashi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (02): : 577 - 586
  • [37] Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization
    Sinha, Neelima
    Karche, Navnath P.
    Verma, Mahip Kalyan
    Walunj, Sameer S.
    Nigade, Prashant B.
    Jana, Gourhari
    Kurhade, Sanjay P.
    Hajare, Anil K.
    Tilekar, Ajay R.
    Jadhav, Ganesh R.
    Thube, Baban R.
    Shaikh, Javed S.
    Balgude, Sudhakar
    Singh, Lairikyengbam Bikramjit
    Mahimane, Vijaya
    Adurkar, Shridhar K.
    Hatnapure, Girish
    Raje, Firoj
    Bhosale, Yogesh
    Bhanage, Dnyaneshwar
    Sachchidanand, Sachchidanand
    Dixit, Ruchi
    Gupta, Rajesh
    Bokare, Anand M.
    Dandekar, Manoj
    Bharne, Ashish
    Chatterjee, Manavi
    Desai, Sagar
    Koul, Sarita
    Modi, Dipak
    Mehta, Maneesh
    Patil, Vinod
    Singh, Minakshi
    Gundu, Jayasagar
    Goel, Rajan N.
    Shah, Chirag
    Sharma, Sharad
    Bakhle, Dhananjay
    Kamboj, Rajender Kumar
    Palle, Venkata P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (03) : 944 - 960
  • [38] Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors
    Tan, Bin
    Zhang, Xiaomeng
    Quan, Xu
    Zheng, Guochuang
    Li, Xue
    Zhao, Liwen
    Li, Wei
    Li, Bo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (16)
  • [39] Further structure activity relationship studies of 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl) phenol and its analogs: Identification of novel triple uptake inhibitors as new generation antidepressants
    Gopishetty, Bhaskar
    Ali, Solav
    Reith, Marteen E. A.
    Dutta, Aloke K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [40] Identification of the Clinical Candidate (R)-(1-(4-Fluoropheny1)-6-((1methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist
    Hunt, Hazel J.
    Belanoff, Joseph K.
    Walters, Iain
    Gourdet, Benoit
    Thomas, Jennifer
    Barton, Naomi
    Unitt, John
    Phillips, Timothy
    Swift, Denise
    Eaton, Emily
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (08) : 3405 - 3421